BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Yao B, Zhang S, Wei Y, et al. (2020) Structural Insights into the Specificity of Ligand Binding and Coactivator Assembly by Estrogen-Related Receptor β. Journal of Molecular Biology |
| Jin L, Wang R, Zhu Y, et al. (2015) Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease. Scientific Reports. 5: 17288 |
| Zheng W, Qiu L, Wang R, et al. (2015) Selective targeting of PPARγ by the natural product chelerythrine with a unique binding mode and improved antidiabetic potency. Scientific Reports. 5: 12222 |
| Yang C, Li Q, Li Y. (2014) Targeting Nuclear Receptors with Marine Natural Products Marine Drugs. 12: 601-635 |
| Jin L, Feng X, Rong H, et al. (2013) The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism. Nature Communications. 4: 1937 |
| Zheng W, Feng X, Qiu L, et al. (2013) Identification of the antibiotic ionomycin as an unexpected peroxisome proliferator-activated receptor γ (PPARγ) ligand with a unique binding mode and effective glucose-lowering activity in a mouse model of diabetes Diabetologia. 56: 401-411 |
| Laurenzana EM, Chen T, Kannuswamy M, et al. (2012) The orphan nuclear receptor DAX-1 functions as a potent corepressor of the constitutive androstane receptor (NR1I3). Molecular Pharmacology. 82: 918-28 |
| Jin L, Li Y. (2010) Structural and functional insights into nuclear receptor signaling. Advanced Drug Delivery Reviews. 62: 1218-26 |
| Jin L, Martynowski D, Zheng S, et al. (2010) Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORgamma. Molecular Endocrinology (Baltimore, Md.). 24: 923-9 |
| Schopfer FJ, Cole MP, Groeger AL, et al. (2010) Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions. The Journal of Biological Chemistry. 285: 12321-33 |